|
Synonyms: Compound 45 [PMID: 458805] | SL 73-033 | SL73-033 | Stakane®
antrafenine is an approved drug
Compound class:
Synthetic organic
Comment: Antrafenine is an old drug that has analgesic and anti-inflammatory properties [3]. More recently (2025) antrafenine was reported to reduce KNa1.1 (KCNT1) channel activity in vitro, and to reduce seizure activity in a Drosophila model of KCNT1-related epilepsy (caused by gain‐of‐function KCNT1 mutations), leading to the hypothesis that suppressing the overactive channels offers a novel therapeutic intervention for this form of genetic epilepsy [4].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. FDA.
antrafenine. Accessed on 02/09/2026. Modified on 02/09/2026. www.accessdata.fda.gov, www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1037524 |
|
2. Leatham PA, Bird HA, Wright V, Seymour D, Gordon A. (1983)
A double blind study of antrafenine, naproxen and placebo in osteoarthrosis. Eur J Rheumatol Inflamm, 6 (2): 209-11. [PMID:6673985] |
|
3. Manoury PM, Dumas AP, Najer H, Branceni D, Prouteau M, Lefevre-Borg FM. (1979)
Synthesis and analgesic activities of some (4-substituted phenyl-1-piperazinyl)alkyl 2-aminobenzoates and 2-aminonicotinates. J Med Chem, 22 (5): 554-9. [PMID:458805] |
|
4. Ricos MG, Cole BA, Hussain R, Rychkov GY, Shaukat Z, Pilati N, Muench SP, Simmons KJ, Dibbens LM, Lippiat JD. (2025)
Identification of New KCNT1-Epilepsy Drugs by In Silico, Cell, and Drosophila Modeling. Ann Neurol, 98 (6): 1261-1274. [PMID:40944494] |